Xtant Medical (XTNT) earnings

Xtant Medical Holdings, Inc.· Health Care

Results to: Jun 2026
Latest analysed call: Jun 2026 (Q2 FY26)
Balance sheet to: Dec 2025

Company research is public. Sign in to keep your own companies, notes and cases.

Xtant Medical earnings: last reported Tue, 11 Aug 2026, for the quarter ended Jun 2026.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

Metric	Value	Change	Basis	Period	Note
Revenue	23.0 $ million	−35.0% YoY	Quarterly, as filed	Quarter to Jun 2026	Revenue from operations as filed.
Operating margin	-39.8 %	−52.9 pts YoY	Operating profit / revenue	Quarter to Jun 2026	For the quarter; a change is in percentage points.
Net profit	-9.4 $ million	−365.2% YoY	Quarterly, as filed	Quarter to Jun 2026	Profit after tax as filed.

Source: Inve data from filed results (SEC filings) · to Jun 2026

Price

$0.29 0.00% · $0

Last close Oct 19, 2026 · US · USD

Performance −59.2% 1Y

1Y: $0.71 on 17 Oct 2025 → $0.29. High $0.92 (30 Oct 2025), low $0.29 (16 Oct 2026).

Previous close: $0.29
52-week range: $0.29 – $0.92
One year: −61.84%

Overview

Symbol: XTNT
Sector: Health Care
Exchange: US
Currency: USD

Financials

What the filings say

Net profit, year on year: −365% (quarter to jun 2026 against jun 2025).

In $ million. Oldest period first.

Line item	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	28	32	33	35	33	32	21	23
Operating profit	-4	-2	1	5	3	-1	-3	-9
Operating margin	−13.5%	−6.0%	3.2%	13.1%	7.6%	−2.9%	−14.0%	−39.8%
Other income	-1	-1	-1	-1	-1	3	-0	-0
Interest	1	1	1	1	1	1	1	1
Profit before tax	-5	-3	0	4	2	2	-3	-9
Tax rate	−1.3%	−0.7%	−75.8%	6.7%	16.4%	96.4%	−0.9%	−0.8%
Net profit	-5	-3	0	4	1	0	-3	-9
EPS ($ per share)	-0.04	—	0	0.03	0.01	—	-0.02	-0.07

Source: Inve data · income statement, quarterly · to Jun 2026

In $ million. Oldest period first.

Line item	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Equity capital	—	—	0	—	—	—	—	—
Reserves	-215	-223	-230	-235	-244	-243	-259	-254
Total liabilities	90	87	27	24	26	41	51	43
Fixed assets	7	5	4	5	6	9	10	6
Total assets	46	43	41	55	60	93	94	94

Source: Inve data · balance sheet · to Dec 2025

In $ million. Oldest period first.

Line item	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from operations	1	-0	-1	0	-5	-10	-12	13
Cash from investing	-0	-1	-1	-2	-2	-25	-4	8
Cash from financing	3	-1	-1	17	9	20	16	-10
Net cash flow	4	-2	-3	16	2	-15	0	11
Capital expenditure	-1	-1	-2	-2	-2	-1	-4	-2
Free cash flow	1	-1	-2	-2	-7	-11	-16	10

Source: Inve data · cash flow · to Dec 2025

Insider filings

21 filings between Nov 15, 2025 and Aug 15, 2026.

Open market

decisions to buy or sell

Nobody bought or sold XTNT on the open market in this window. The filings below are 16 awards and 5 tax withholdings.

Compensation

not trading decisions

16: Award — granted as compensation
5: Tax withheld — shares kept back by the company to cover tax

Latest filings (28)

Date	Insider	What	Shares	Value
Aug 15, 2026	Lipschultz Tyler Director	Award	215,517	$0
Aug 15, 2026	BAKEWELL JOHN K Director	Award	215,517	$0
Aug 15, 2026	Vizirgianakis Stavros G. Director	Award	323,275	$0
Aug 15, 2026	Browne Sean E President and CEO	Award	550,000	$0
Aug 15, 2026	Browne Sean E President and CEO	Tax withheld	10,605	$3.3K
Aug 15, 2026	Neils Scott C CFO and Assistant Secretary	Award	400,000	$0
Aug 15, 2026	Neils Scott C CFO and Assistant Secretary	Tax withheld	28,155	$8.7K
Aug 15, 2026	Schallenberger Mark A. Chief Operating Officer	Award	450,000	$0
Aug 15, 2026	Schallenberger Mark A. Chief Operating Officer	Tax withheld	7,070	$2.2K
Aug 15, 2026	Beeson Jonn R. Director	Award	215,517	$0
Aug 15, 2026	JAIN ABHINAV Director	Award	215,517	$0
Feb 15, 2026	Schallenberger Mark A. Chief Operating Officer	Tax withheld	7,709	$4.5K
Jan 15, 2026	Neils Scott C CFO and Assistant Secretary	Tax withheld	8,084	$5.3K
Nov 15, 2025	Vizirgianakis Stavros G. Director	Award	553,797	$0
Nov 15, 2025	Lipschultz Tyler Director	Award	158,228	$0
Nov 15, 2025	Browne Sean E President and CEO	Award	394,937	$0
Nov 15, 2025	Neils Scott C CFO and Assistant Secretary	Award	263,291	$0
Nov 15, 2025	Schallenberger Mark A. Chief Operating Officer	Award	292,253	$0
Nov 15, 2025	Beeson Jonn R. Director	Award	158,228	$0
Nov 15, 2025	JAIN ABHINAV Director	Award	158,228	$0
Nov 15, 2025	BAKEWELL JOHN K Director	Award	158,228	$0
Aug 15, 2025	Browne Sean E President and CEO	Tax withheld	10,605	$6.7K
Aug 15, 2025	Neils Scott C CFO	Tax withheld	34,131	$21.5K
Apr 10, 2025	ORBIMED ADVISORS LLC 10% owner	Sale	17,109,618	$7.19M
Apr 10, 2025	ORBIMED ADVISORS LLC 10% owner	Sale	56,004,974	$23.52M
Jan 15, 2025	Neils Scott C Chief Financial Officer	Tax withheld	7,986	$4.2K
Oct 15, 2024	Browne Sean E President and CEO	Tax withheld	105,442	$62.2K
Apr 3, 2024	Schallenberger Mark A. Chief Operations Officer	Award	173,469	$0

Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.

Your own record

Start an Inve Case for Xtant Medical Holdings, Inc.

Free account. Everything above stays public.

Write why you follow Xtant Medical Holdings, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading